Skip to main content
RT @NoufAhmedAlham2: Any dose more than 1500 is associated with retinopathy ? So what to do. ⁦@Lupusreference⁩ #RNL

Nouf Al hemmadi NoufAhmedAlham2

3 years 7 months ago
Any dose more than 1500 is associated with retinopathy ? So what to do. ⁦@Lupusreference⁩ #RNL2023 ⁦@RheumNow⁩ https://t.co/2zdjpcuvKa
RT @ericdeinmd: Smoking and SLE
Smoking increases SLE activity
Smoking decreases HCQ efficacy
Skin response on HCQ down

Eric Dein ericdeinmd

3 years 7 months ago
Smoking and SLE Smoking increases SLE activity Smoking decreases HCQ efficacy Skin response on HCQ down 50% in smokers 🚬 @Lupusreference #RNL2023 @RheumNow
RT @NoufAhmedAlham2: TULIP trials in lupus, disease outcomes and others, by Richard Furie #RNL2023 ⁦@RheumNow⁩ https

Nouf Al hemmadi NoufAhmedAlham2

3 years 7 months ago
TULIP trials in lupus, disease outcomes and others, by Richard Furie #RNL2023 ⁦@RheumNow⁩ https://t.co/uUQOxUIzJN
RT @ericdeinmd: Dr. Furie: #RNL2023
Anifrolumab - anti type 1 IFN receptor- blocks all 5 IFN, 90% IFN gene signature dec

Eric Dein ericdeinmd

3 years 7 months ago
Dr. Furie: #RNL2023 Anifrolumab - anti type 1 IFN receptor- blocks all 5 IFN, 90% IFN gene signature decrease Improved from prior older failed medication sifalimumab which only blocked IFNalpha- only 25% interferon gene signature @RheumNow https://t.co/30oFRwwuTG
RT @Lupusreference: ✅ Check my TAKE-HOME MESSAGES about #hydroxychloroquine & #Lupus for RheumNow Live 2023 #RNL20

Laurent ARNAUD Lupusreference

3 years 7 months ago
✅ Check my TAKE-HOME MESSAGES about #hydroxychloroquine & #Lupus for RheumNow Live 2023 #RNL2023 @RheumNow ⬇️ https://t.co/E2xdv3ODG6
RT @NoufAhmedAlham2: SRI Responders more likely able to reduce prednisone and far

Serological improvement
SF-36
Fati

Nouf Al hemmadi NoufAhmedAlham2

3 years 7 months ago
SRI Responders more likely able to reduce prednisone and far Serological improvement SF-36 Fatigue by Richard Furie #RNL2023 ⁦@RheumNow⁩ https://t.co/ilsyOXw7nA
RT @NoufAhmedAlham2: Compliance is always an issue, by Richard Furie #RNL2023 ⁦@RheumNow⁩ .

Plaquenil level were b

Nouf Al hemmadi NoufAhmedAlham2

3 years 7 months ago
Compliance is always an issue, by Richard Furie #RNL2023 ⁦@RheumNow⁩ . Plaquenil level were below target. Adherence is always something we need to work on. https://t.co/hMgL9kY0rZ
RT @doctorRBC: Dr. Ken Kalunian on Lupus nephritis
Don't forget about ACEi/ARB therapy for SLE pts with renal involvemen

Robert B Chao, MD doctorRBC

3 years 7 months ago
Dr. Ken Kalunian on Lupus nephritis Don't forget about ACEi/ARB therapy for SLE pts with renal involvement - can control BP - reduce Urine proteinuria - decrease risk of active renal disease #RNL2023 @RheumNow https://t.co/hLBqjELqW2
RT @NoufAhmedAlham2: UPCR< 500 mg is the best predictor of a renal outcome in lupus nephritis. Multiple creatinine te

Nouf Al hemmadi NoufAhmedAlham2

3 years 7 months ago
UPCR< 500 mg is the best predictor of a renal outcome in lupus nephritis. Multiple creatinine testing, Ken Kalunian #RNL2023 ⁦@RheumNow⁩ https://t.co/96PlXgqOfK
RT @NoufAhmedAlham2: Belimumab in Active lupus nephritis , Ken Kalunian #RNL2023 ⁦@RheumNow⁩ https://t.co/VZkmK8Iny7

Nouf Al hemmadi NoufAhmedAlham2

3 years 7 months ago
Belimumab in Active lupus nephritis , Ken Kalunian #RNL2023 ⁦@RheumNow⁩ https://t.co/VZkmK8Iny7
Carpal Tunnel - Steroid injection vs. Night Splinting

A randomized trial conducted by the UK National Health Service,

Dr. John Cush RheumNow

3 years 7 months ago
Carpal Tunnel - Steroid injection vs. Night Splinting A randomized trial conducted by the UK National Health Service, studied interventions in patients with CTS and found no advantage to either CTS CSIor NS as the initial treatment of CTS. https://t.co/dcE2P6RqoC https://t.co/pykkXs8qqi
RT @NoufAhmedAlham2: Risk of adverse outcomes in PsA pregnancies

More pre eclampsia
More Cesarian section
More preter

Nouf Al hemmadi NoufAhmedAlham2

3 years 7 months ago
Risk of adverse outcomes in PsA pregnancies More pre eclampsia More Cesarian section More preterms By Dr.Chambers #RNL2023 ⁦@RheumNow⁩ https://t.co/LRiSSpv4Yj
RT @gurdeep_dulay: Smoking *may* only ⬆️ risk of #RA if shared epitope present AND double positive

By @Janetbirdop

Dr Gurdeep Dulay gurdeep_dulay

3 years 7 months ago
Smoking *may* only ⬆️ risk of #RA if shared epitope present AND double positive By @Janetbirdope #RNL2023 https://t.co/TG1hseVCsD
RT @ericdeinmd: #RNL2023 Year in Review
@andreafava: urinary biomarkers in lupus nephritis
CD163, IL-16, CD206 decrease

Eric Dein ericdeinmd

3 years 7 months ago
#RNL2023 Year in Review @andreafava: urinary biomarkers in lupus nephritis CD163, IL-16, CD206 decrease at 3 months. Urinary biomarkers predict 1 year proteinuric response, esp in prolif LN. Liquid biopsy as way to monitor instead of serial biopsies @RheumNow https://t.co/baZt57Qjne
RT @doctorRBC: Dr. Eric Ruderman with an excellent review of the JAK/STAT pathway especially for PsA treatment
@RheumNow

Robert B Chao, MD doctorRBC

3 years 7 months ago
Dr. Eric Ruderman with an excellent review of the JAK/STAT pathway especially for PsA treatment @RheumNow #RNL2023 https://t.co/kNDouZ4kCV
×